Edition:
India

Alpine Immune Sciences Inc (ALPN.OQ)

ALPN.OQ on NASDAQ Stock Exchange Global Market

4.63USD
22 Aug 2019
Change (% chg)

-- (--)
Prev Close
$4.63
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
2,632
52-wk High
$7.99
52-wk Low
$3.46

About

Alpine Immune Sciences, Inc., formerly Nivalis Therapeutics, Inc., is focused on developing a protein-based immunotherapies using Variant immunoglobulin domain (vlgD) platform technology. The vlgD platform is designed to interact with multiple targets, including many present in the immune synapse. The vlgDs are developed using a... (more)

Overall

Beta: --
Market Cap(Mil.): $168.94
Shares Outstanding(Mil.): 13.88
Dividend: --
Yield (%): --

Financials

Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates